Eagle Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,427,922
Closed -$16.5M 651
2017
Q4
$16.5M Sell
1,427,922
-3,145
-0.2% -$35.1K 0.09% 257
2017
Q3
$17.6M Sell
1,431,067
-325,440
-19% -$3.39M 0.1% 270
2017
Q2
$20.1M Buy
1,756,507
+601,242
+52% +$11.1M 0.12% 237
2017
Q1
$24M Buy
1,155,265
+35,726
+3% +$791K 0.15% 199
2016
Q4
$23.3M Buy
1,119,539
+5,001
+0.4% +$130K 0.15% 196
2016
Q3
$36.5M Sell
1,114,538
-5,078
-0.5% -$155K 0.25% 124
2016
Q2
$28M Sell
1,119,616
-23,477
-2% -$635K 0.19% 158
2016
Q1
$28M Sell
1,143,093
-53,412
-4% -$1.24M 0.19% 165
2015
Q4
$39.5M Buy
1,196,505
+36,274
+3% +$1.23M 0.26% 133
2015
Q3
$38M Sell
1,160,231
-226,739
-16% -$9.64M 0.26% 131
2015
Q2
$73.5M Buy
1,386,970
+259,737
+23% +$9.45M 0.41% 80
2015
Q1
$32.5M Buy
+1,127,233
New +$30.9M 0.19% 169

Other funds holding ALDR